MosKa - energy for adults
MosKa - energy for adults (Batch Number MOSK-1235302) poses a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled as MosKa- energy for adults (Batch Number MOSK-1235302) and found that:
- it contains the undeclared substance vardenafil above the allowable prescription level in Australia;
- consumers are advised that vardenafil is a prescription-only substance (which is the active ingredient in the approved medicine Levitra) indicated for the treatment of erectile dysfunction.
The supply of MosKa - energy for adults (Batch Number MOSK-1235302) is illegal.
MosKa - energy for adults (Batch Number MOSK-1235302) has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that people in Australia may have bought the product online.
Information for consumers
- Stop taking MosKa - energy for adults (Batch Number MOSK-1235302) and take any of the remaining product to your local pharmacy for safe disposal.
- If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with Australian Customs and Border Protection Service (Customs) to help stop future shipments of MosKa - energy for adults (Batch Number MOSK-1235302) from entering Australia.
If these bottles are found at the border by Customs they will be seized and destroyed.
The TGA is advising consumers to exercise extreme caution when purchasing medicines from unknown overseas Internet sites. Products purchased over the Internet:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.
Report counterfeit medicines and medical devices
If you are worried about counterfeit medicines or medical devices, and want to report an issue, you can report the matter to the TGA:
|Phone:||1800 020 653|
|Online:||Report a perceived breach of the Therapeutic Goods Act or questionable practices relating to therapeutic products|